523 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of AtTEnd/ENGOT-EN7 trial
S. Nishio, Beatriz Pardo, E. Hudson, Eliana Rulli, Y. Antill, Chulmin Lee, M. Rabaglio, Florian Heitz, Katharina Leitner, C-H. Lai, Sara Uggeri, Luis Manso, K. Harano, K. Allan, Yeh Chen Lee, G. Tognon, Stefania Canova, M. C. Petrella, A. Gadducci, N. Colombo
{"title":"523 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of AtTEnd/ENGOT-EN7 trial","authors":"S. Nishio, Beatriz Pardo, E. Hudson, Eliana Rulli, Y. Antill, Chulmin Lee, M. Rabaglio, Florian Heitz, Katharina Leitner, C-H. Lai, Sara Uggeri, Luis Manso, K. Harano, K. Allan, Yeh Chen Lee, G. Tognon, Stefania Canova, M. C. Petrella, A. Gadducci, N. Colombo","doi":"10.1136/ijgc-2024-esgo.26","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"33 33","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
